Goldman leads €6bn Novartis bids

Goldman Sachs is understood to have won the lead advisory role on two deals announced today by Novartis. Credit Suisse First Boston, a regular adviser to the Swiss drugs giant, has no advisory role.

Senior banking sources said Goldman was advising Novartis on both deals.

WSJ Logo
Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With TrumpExternal link

Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With Trump